Viewing Study NCT04240704


Ignite Creation Date: 2025-12-24 @ 9:12 PM
Ignite Modification Date: 2025-12-25 @ 7:01 PM
Study NCT ID: NCT04240704
Status: TERMINATED
Last Update Posted: 2025-10-10
First Post: 2020-01-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module